Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer  Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,

Published byInge Pranoto Modified over 6 years ago

Similar presentations

Presentation on theme: "Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer  Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,"— Presentation transcript:

1 Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer 
Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD, Tomomi Hirata, MD, Iwao Mikami, MD, Mitsuhiro Fukushima, MD, Shigeki Yamagishi, MD, Tetsuo Kawashima, MD, Daisuke Okada, MD, Kazuo Shimizu, MD, Masashi Kawamoto, MD  The Annals of Thoracic Surgery  Volume 79, Issue 1, Pages (January 2005) DOI: /j.athoracsur Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Immunohistochemical staining patterns for maspin and p53 in non–small cell lung cancer and normal lung tissue. (A) Weak immunostaining for maspin surrounding the nucleus of bronchial gland epithelial cells in normal lung tissue and negative staining in normal alveolar epithelial cells (magnification, ×200). (B, C) Strong immunostaining for maspin in cytoplasm of adenocarcinoma and squamous cell carcinoma, and negative staining of stromal cells (magnification, ×200). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Reverse transcription–polymerase chain reaction analysis of maspin and β-actin messenger ribonucleic acid in normal lung tissues and cancer tissues of 3 different patients. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 (A) Maspin/β-actin ratio from semiquantification of reverse transcription–polymerase chain reaction products in normal tissues and cancer tissues (mean ± standard deviation). (B) Comparative tumor/nontumor (T/N) ratios for maspin messenger ribonucleic acid (mean ± standard deviation) in stage I (n = 15), stage II (n = 10), and stage III (n = 15). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Kaplan-Meier survival of non–small cell lung cancer patients on the basis of maspin immunoreactivity using the Wilcoxon statistic. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer  Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,"

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.

A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size  Shigeki Suzuki, MD, Hiroyuki Sakurai, MD, Kyohei.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Bronchial Carcinoid Secreting Insulin-Like Growth Factor-1 With Acromegalic Features  Joseph D. Phillips, MD, Anjana Yeldandi, MD, Mathew Blum, MD, Alberto.

Bronchial Carcinoid Secreting Insulin-Like Growth Factor-1 With Acromegalic Features  Joseph D. Phillips, MD, Anjana Yeldandi, MD, Mathew Blum, MD, Alberto.
Association of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus-Infected Lung Cancer Patients  Shih-Pin Chen, MD, Nan-Yung Hsu, MD,

Association of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus-Infected Lung Cancer Patients  Shih-Pin Chen, MD, Nan-Yung Hsu, MD,
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Similar presentations

Ads by Google